Annual Total Debt
$262.00 K
+$91.00 K+53.22%
31 December 2023
Summary:
ReShape Lifesciences annual total debt is currently $262.00 thousand, with the most recent change of +$91.00 thousand (+53.22%) on 31 December 2023. During the last 3 years, it has fallen by -$12.99 million (-98.02%). RSLS annual total debt is now -98.08% below its all-time high of $13.67 million, reached on 31 December 2008.RSLS Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Debt
$191.00 K
-$25.00 K-11.57%
30 September 2024
Summary:
ReShape Lifesciences quarterly total debt is currently $191.00 thousand, with the most recent change of -$25.00 thousand (-11.57%) on 30 September 2024. Over the past year, it has dropped by -$94.00 thousand (-32.98%). RSLS quarterly total debt is now -98.97% below its all-time high of $18.51 million, reached on 30 June 2009.RSLS Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RSLS Total Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +53.2% | -33.0% |
| 3 y3 years | -98.0% | -94.5% |
| 5 y5 years | +100.0% | -77.2% |
RSLS Total Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -98.0% | +53.2% | -94.5% | +122.1% |
| 5 y | 5 years | -98.0% | -98.6% | +122.1% | |
| alltime | all time | -98.1% | -99.0% |
ReShape Lifesciences Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $191.00 K(-11.6%) |
| June 2024 | - | $216.00 K(-9.6%) |
| Mar 2024 | - | $239.00 K(-8.8%) |
| Dec 2023 | $262.00 K(+53.2%) | $262.00 K(-8.1%) |
| Sept 2023 | - | $285.00 K(-7.2%) |
| June 2023 | - | $307.00 K(+257.0%) |
| Mar 2023 | - | $86.00 K(-49.7%) |
| Dec 2022 | $171.00 K(-38.7%) | $171.00 K(-32.9%) |
| Sept 2022 | - | $255.00 K(-24.6%) |
| June 2022 | - | $338.00 K(-35.9%) |
| Mar 2022 | - | $527.00 K(+88.9%) |
| Dec 2021 | $279.00 K(-97.9%) | $279.00 K(-91.9%) |
| Sept 2021 | - | $3.44 M(-4.3%) |
| June 2021 | - | $3.60 M(+795.5%) |
| Mar 2021 | - | $402.00 K(-97.0%) |
| Dec 2020 | $13.25 M(+1625.8%) | $13.25 M(+2301.1%) |
| Sept 2020 | - | $552.00 K(-11.8%) |
| June 2020 | - | $626.00 K(-10.4%) |
| Mar 2020 | - | $699.00 K(-9.0%) |
| Dec 2019 | $768.00 K(>+9900.0%) | $768.00 K(-8.2%) |
| Sept 2019 | - | $837.00 K(-13.6%) |
| June 2019 | - | $969.00 K(-62.4%) |
| Mar 2019 | - | $2.58 M(>+9900.0%) |
| Dec 2018 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2018 | - | $0.00(0.0%) |
| June 2018 | - | $0.00(0.0%) |
| Mar 2018 | - | $0.00(0.0%) |
| Dec 2017 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2017 | - | $0.00(0.0%) |
| June 2017 | - | $0.00(0.0%) |
| Mar 2017 | - | $0.00(0.0%) |
| Dec 2016 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sept 2016 | - | $5.68 M(-60.4%) |
| June 2016 | - | $14.34 M(+33.3%) |
| Mar 2016 | - | $10.76 M(+748.8%) |
| Dec 2015 | $1.27 M(-57.4%) | $1.27 M(>+9900.0%) |
| Sept 2015 | - | $0.00(-100.0%) |
| June 2015 | - | $997.80 K(-49.9%) |
| Mar 2015 | - | $1.99 M(-33.1%) |
| Dec 2014 | $2.98 M | $2.98 M(-24.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2014 | - | $3.96 M(-19.8%) |
| June 2014 | - | $4.93 M(-16.4%) |
| Mar 2014 | - | $5.90 M(-14.1%) |
| Dec 2013 | $6.87 M(-29.1%) | $6.87 M(-12.3%) |
| Sept 2013 | - | $7.83 M(-10.9%) |
| June 2013 | - | $8.78 M(-9.8%) |
| Mar 2013 | - | $9.73 M(+0.5%) |
| Dec 2012 | $9.68 M(+86.6%) | $9.68 M(+0.5%) |
| Sept 2012 | - | $9.63 M(+0.5%) |
| June 2012 | - | $9.58 M(+105.3%) |
| Mar 2012 | - | $4.67 M(-10.0%) |
| Dec 2011 | $5.19 M(-12.1%) | $5.19 M(-8.9%) |
| Sept 2011 | - | $5.70 M(+0.9%) |
| June 2011 | - | $5.65 M(+0.8%) |
| Mar 2011 | - | $5.60 M(-5.2%) |
| Dec 2010 | $5.91 M(-23.9%) | $5.91 M(+1.3%) |
| Sept 2010 | - | $5.83 M(-3.6%) |
| June 2010 | - | $6.05 M(-12.7%) |
| Mar 2010 | - | $6.93 M(-10.7%) |
| Dec 2009 | $7.76 M(-43.2%) | $7.76 M(-54.3%) |
| Sept 2009 | - | $17.00 M(-8.2%) |
| June 2009 | - | $18.51 M(+33.9%) |
| Mar 2009 | - | $13.83 M(+1.2%) |
| Dec 2008 | $13.67 M(+23.2%) | $13.67 M(+87.6%) |
| Sept 2008 | - | $7.29 M(-15.3%) |
| June 2008 | - | $8.60 M(-12.1%) |
| Mar 2008 | - | $9.79 M(-11.7%) |
| Dec 2007 | $11.10 M(+153.5%) | $11.10 M(+16.4%) |
| Sept 2007 | - | $9.53 M(>+9900.0%) |
| June 2007 | - | $0.00(0.0%) |
| Mar 2007 | - | $0.00(-100.0%) |
| Dec 2006 | $4.38 M(-47.5%) | $4.38 M(>+9900.0%) |
| Sept 2006 | - | $0.00(0.0%) |
| June 2006 | - | $0.00(0.0%) |
| Mar 2006 | - | $0.00(-100.0%) |
| Dec 2005 | $8.34 M(>+9900.0%) | $8.34 M(>+9900.0%) |
| Sept 2005 | - | $0.00(0.0%) |
| June 2005 | - | $0.00(0.0%) |
| Mar 2005 | - | $0.00 |
| Dec 2004 | $0.00(0.0%) | - |
| Dec 2003 | $0.00 | - |
FAQ
- What is ReShape Lifesciences annual total debt?
- What is the all time high annual total debt for ReShape Lifesciences?
- What is ReShape Lifesciences annual total debt year-on-year change?
- What is ReShape Lifesciences quarterly total debt?
- What is the all time high quarterly total debt for ReShape Lifesciences?
- What is ReShape Lifesciences quarterly total debt year-on-year change?
What is ReShape Lifesciences annual total debt?
The current annual total debt of RSLS is $262.00 K
What is the all time high annual total debt for ReShape Lifesciences?
ReShape Lifesciences all-time high annual total debt is $13.67 M
What is ReShape Lifesciences annual total debt year-on-year change?
Over the past year, RSLS annual total debt has changed by +$91.00 K (+53.22%)
What is ReShape Lifesciences quarterly total debt?
The current quarterly total debt of RSLS is $191.00 K
What is the all time high quarterly total debt for ReShape Lifesciences?
ReShape Lifesciences all-time high quarterly total debt is $18.51 M
What is ReShape Lifesciences quarterly total debt year-on-year change?
Over the past year, RSLS quarterly total debt has changed by -$94.00 K (-32.98%)